355 related articles for article (PubMed ID: 3496428)
21. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
23. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
[TBL] [Abstract][Full Text] [Related]
24. Glucose consumption in recurrent gliomas.
Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
[TBL] [Abstract][Full Text] [Related]
25. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic significance of regional blood flow, blood volume, oxygen extraction fraction, and metabolic rates of oxygen and glucose as measured by positron emission tomography in patients with gliomas].
Mineura K; Suda Y; Sasajima T; Yasuda T; Kowada M; Ogawa T; Shishido F; Uemura K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2556-62. PubMed ID: 2614191
[TBL] [Abstract][Full Text] [Related]
27. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
28. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
[TBL] [Abstract][Full Text] [Related]
29. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
[TBL] [Abstract][Full Text] [Related]
31. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
Rozental JM; Levine RL; Nickles RJ; Dobkin JA
Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
[TBL] [Abstract][Full Text] [Related]
32. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
[TBL] [Abstract][Full Text] [Related]
33. [Radiochemotherapy-related changes in the brain parenchyma of glioma patients evaluated repeatedly by C15O2, C15O, 15O2, and 18F-fluorodeoxyglucose (FDG) PET].
Mineura K; Suda Y; Sasajima T; Kowada M; Ogawa T; Shishido F; Uemura K
No Shinkei Geka; 1989 Oct; 17(10):945-52. PubMed ID: 2510045
[TBL] [Abstract][Full Text] [Related]
34. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
35. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
36. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method.
Schmidt K; Lucignani G; Moresco RM; Rizzo G; Gilardi MC; Messa C; Colombo F; Fazio F; Sokoloff L
J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447
[TBL] [Abstract][Full Text] [Related]
37. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
Fulham MJ; Brunetti A; Aloj L; Raman R; Dwyer AJ; Di Chiro G
J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
[TBL] [Abstract][Full Text] [Related]
38. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
Kim CK; Alavi JB; Alavi A; Reivich M
J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomographic study of suppression of gray-matter glucose utilization by brain tumors.
DeLaPaz RL; Patronas NJ; Brooks RA; Smith BH; Kornblith PL; Milam H; Di Chiro G
AJNR Am J Neuroradiol; 1983; 4(3):826-9. PubMed ID: 6308993
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
